Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONWARD phase 3 trial of AD04 in genetically selected adults with alcohol use disorder
2019-000737-39Phase 3Completed
- Sponsor
- Adial Pharmaceuticals, Inc.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing AD04 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2019-000737-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000737-39.